Table 4.
All patients | Patients with PH group 1 (n = 14) | Patients with PH group 2 (n = 23) | Patients with PH group 4 (n = 8) | |
---|---|---|---|---|
Characteristics | ||||
Age | 64 | 59 | 67 | 62 |
Female | 28 | 8 | 11 | 3 |
CHD | 10 | 1 | 6 | 3 |
Echocardiography | ||||
sPAP (mm Hg) | 58 | 66 | 52 | 68 |
LA-diameter (mm) | 50 | 41 | 60 | 41 |
LV-diameter (mm) | 49 | 44 | 53 | 45 |
LV-EF (reduction) | No: 32 | No: 13 | No: 7 | No: 4 |
Low: 13 | Low: 1 | Low: 9 | Low: 2 | |
Middle: 5 | Middle: — | Middle: 3 | Middle: 2 | |
High: 4 | High: — | High: 4 | High: — | |
RA-diameter (mm) | 58 | 61 | 57 | 59 |
RV-diameter (mm) | 43 | 46 | 38 | 50 |
TAPSE (mm) | 16.5 | 16 | 16 | 15 |
TEI-Index | 0.55 | 0.6 | 0.52 | 0.55 |
AT (msec) | 81 | 73 | 79 | 73 |
LVH (n) | 17 | 1 | 10 | 3 |
Right heart catheterization | ||||
PCWP (mm Hg) | 15 | 9 | 22 | 10 |
mPAP (mm Hg) | 42 | 43 | 41 | 42 |
PVR (dyn s cm−5) | 647 | 835 | 515 | 640 |
RAP (mm Hg) | 9 | 8 | 11 | 9 |
CO (L/min) | 3.9 | 3.5 | 3.9 | 4.1 |
CHD: coronary heart disease, sPAP: systolic pulmonary arterial pressure, LA/RA=left/right atrium, LV/RV: left/right ventricle, EF: ejection fraction, TAPSE: tricuspid annular plane systolic excursion, AT: acceleration time, LVH: left ventricle hypertrophy, PCWP: pulmonary capillary wedge pressure, mPAP: mean pulmonary arterial pressure, PVR: pulmonary vascular resistance, RAP: right atrial pressure, and CO: cardiac output (litres (L) per minute (min)).